Skip to main content
. Author manuscript; available in PMC: 2017 Jul 19.
Published in final edited form as: J Thorac Cardiovasc Surg. 2016 Sep 19;153(1):118–125.e1. doi: 10.1016/j.jtcvs.2016.09.016

TABLE 2.

Excluded patients: Patients who received care on the goal-directed perfusion protocol but were excluded from the final analysis

Patient Age, y Procedure Reason for exclusion Baseline Cr Postoperative peak Cr<72 h
1 50 LV mass excision No comparable procedure 1.5 1.4
2 62 CABG × 4 Preoperative ECMO and AKI requiring CVVHD
3 49 CABG × 2 Preoperative ESRD
4 86 CABG × 3 No match available 1.3 2.3
5 54 OHT Tacrolimus toxicity 1.5 3.4
6 77 Robotic tricuspid valve repair No match available 1.3 1.5
7 51 AVR No match available 1.3 1.3
8 77 CABG × 4 Reoperation excluded (index CABG was included) 1.4 1.6
9 76 CABG × 3 Preoperative ESRD
10 64 CABG × 3 No match available 1.1 1.0
11 78 CABG × 3 and LV thrombectomy VF arrest on transfer from OR to ICU 1.6 1.4
12 56 CABG × 3 Preoperative ESRD

Serum creatinine in milligrams/deciliter. Cr, Creatinine; LV, left ventricle; CABG, coronary artery bypass grafting; ECMO, extracorporeal membrane oxygenation; AKI, acute kidney injury; CVVHD, continuous venovenous hemodialysis; ESRD, end-stage renal disease on dialysis; OHT, orthotopic heart transplantation; AVR, aortic valve replacement; VF, ventricular fibrillation; OR, operating room; ICU, intensive care unit.